CONFERENCE OVERVIEW
July 11-14, 2010
Four Seasons Resort
Teton Village, Wyoming
Mission Statement
The Cerebrovascular Complications Conference (3C) is a multidisciplinary annual meeting committed to a dynamic, honest, and open discussion of complications related to the microsurgical and endovascular management of complex cerebrovascular pathology. Using a case discussion format, the exchange of ideas among physicians, scientists, and other health care professionals will be facilitated and encouraged in a confidential environment. Through open dialogue, 3C hopes to enhance physician education, stimulate progress in the field of cerebrovascular surgery, and improve patient care.
The Cerebrovascular Complications Conference (3C) is a multidisciplinary annual meeting committed to a dynamic, honest, and open discussion of complications related to the microsurgical and endovascular management of complex cerebrovascular pathology. Using a case discussion format, the exchange of ideas among physicians, scientists, and other health care professionals will be facilitated and encouraged in a confidential environment. Through open dialogue, 3C hopes to enhance physician education, stimulate progress in the field of cerebrovascular surgery, and improve patient care.
Learning Objectives
Upon completion of this program, participants should be able to:
Upon completion of this program, participants should be able to:
1. Develop insight into factors that lead to complications and poor outcomes when treating stroke and neurovascular diseases with microsurgical and catheter-based interventional techniques.
2. Identify imaging characteristics of cerebrovascular disease that determine selection criteria and strategies for intervention.
3. Recognize complications specific to cerebrovascular procedures and disease.
4. Identify specific co-morbidities, its impact on vascular intervention, and the management of complications induced by co-morbidity.
5. Evaluate the application of microsurgical techniques for treatment of cerebrovascular disease.
6. Evaluate the application of endovascular techniques and technologies for the treatment of cerebrovascular disease.
7. Develop treatment plans that may aid in reducing the incidence of therapeutic complications and thereby reduce the overall rate of morbidity and mortality.
8. Evaluate new technologies in the use of treating cerebrovascular disease.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AANS and Strategic Medical Seminars, LLC. The AANS is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AANS and Strategic Medical Seminars, LLC. The AANS is accredited by the ACCME to provide continuing medical education for physicians.
The AANS designates this educational activity for a maximum of 18.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure
AANS and Strategic Medical Seminars, LLC control the content and production of this CME activity and attempt to assure the presentation of balanced, objective information. In accordance with the Standards established by the Accreditation Council for Continuing Medical Education, speakers and paper presenters are asked to disclose any relationships they have with commercial companies, which may be related to the content of their lecture.
AANS and Strategic Medical Seminars, LLC control the content and production of this CME activity and attempt to assure the presentation of balanced, objective information. In accordance with the Standards established by the Accreditation Council for Continuing Medical Education, speakers and paper presenters are asked to disclose any relationships they have with commercial companies, which may be related to the content of their lecture.
Intended Audience
This conference is designed for neurosurgeons, interventional neuroradiologists, neurologists, scientists, and all practitioners involved in interventional procedures.
This conference is designed for neurosurgeons, interventional neuroradiologists, neurologists, scientists, and all practitioners involved in interventional procedures.